← Back to Search

Nutrition Education Program for Type 2 Diabetes and Colorectal Cancer

N/A
Recruiting
Led By Lucy Kibe, DrPH
Research Sponsored by Charles Drew University of Medicine and Science
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Our intervention will include patients age 35-44 due to the reported incidence of CRC at an earlier age among diabetic patients
Diabetes type 2 diagnosis
Timeline
Screening 3 weeks
Treatment Varies
Follow Up immediately and 6-months post-intervention
Awards & highlights

Study Summary

This trial observes the impact of a tailored education program on colorectal cancer screening & dietary habits in minority patients w/ type 2 diabetes.

Who is the study for?
This trial is for minority individuals aged 35-75 with Type 2 diabetes, who have visited KCHC in the past two years and can provide contact information. It's not for those with certain digestive diseases, a history of colorectal cancer or related treatments, cognitive impairments, or those already in another diet program.Check my eligibility
What is being tested?
The study tests if a culturally tailored education program on colorectal cancer prevention and nutrition can increase knowledge and screening rates among minorities with Type 2 diabetes. Participants will attend eight sessions and use an educational booklet.See study design
What are the potential side effects?
Since this is an educational intervention rather than a medical treatment, there are no direct side effects like you'd expect from medication. However, changes in diet as recommended by the program may lead to temporary digestive adjustments.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 35 and 44 years old.
Select...
I have been diagnosed with type 2 diabetes.
Select...
I am between 35 and 75 years old.
Select...
My gender does not limit my participation.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~immediately and 6-months post-intervention
This trial's timeline: 3 weeks for screening, Varies for treatment, and immediately and 6-months post-intervention for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
CRC-KPSS change and screening uptake

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Intervention Group (IG)Experimental Treatment1 Intervention
Participants randomized to the IG will receive a customized patient-centered, culturally appropriate education program. Patients randomized to the IG will participate in eight (8) education sessions. A booklet with colorectal cancer education and nutrition education will be developed and print materials given to the participants to use as a workbook.
Group II: Usual Care (UC)Active Control1 Intervention
Patients randomized to UC group will continue to receive care at the clinic without any intervention from the study team.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Intervention Group (IG)
2015
N/A
~3410

Find a Location

Who is running the clinical trial?

Charles Drew University of Medicine and ScienceLead Sponsor
51 Previous Clinical Trials
6,517 Total Patients Enrolled
Lucy Kibe, DrPHPrincipal InvestigatorCharles Drew University of Medicine and Science

Media Library

Intervention Group (IG) Clinical Trial Eligibility Overview. Trial Name: NCT05765214 — N/A
Type 2 Diabetes Research Study Groups: Usual Care (UC), Intervention Group (IG)
Type 2 Diabetes Clinical Trial 2023: Intervention Group (IG) Highlights & Side Effects. Trial Name: NCT05765214 — N/A
Intervention Group (IG) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05765214 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any particular candidates who are best suited for participation in this research?

"This medical trial is seeking approximately 120 candidates with colorectal cancer, aged between 35 and 75 years old."

Answered by AI

Does this clinical trial consider participants of all ages, including those younger than 65?

"This medical study requires potential participants to be between 35 and 75 years old. 233 trials are available for those younger than 18, while 2174 can accommodate individuals aged 65 or above."

Answered by AI

Is the protocol for this research project currently accepting applicants?

"Regrettably, this particular trial is not actively recruiting participants at the moment. The clinical trial was first published on May 1st 2023, with its latest update occurring in March of that same year. Although inactive now, there are 2529 other trials currently being conducted and seeking enrolment from volunteers across the world."

Answered by AI

Who else is applying?

What site did they apply to?
Charles R. Drew University
What portion of applicants met pre-screening criteria?
Met criteria
~77 spots leftby Dec 2025